2021年8月2日简报:德尔塔变异病毒导致全球病例激增,R0高达9,需要全新的防疫措施

2021-08-02 MedSci整理 MedSci整理

截至北京时间2021年8月2日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过19896万例,新增460,678例,达到198,969,763

截至北京时间2021年8月2日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎COVID-19)病例超过19896万例,新增460,678例,达到198,969,763例。累计死亡病例423.9万例,达到4,239,563例。新增死亡为7,115例。康复为179,593,481例,重症和危重症病人达到90,215例,再次超9万;全球新冠确诊病例超过100万例的国家达31个,105个国家病例超10万例。昨日报道:2021年8月1日简报:德尔塔(Delta)毒株R0高达8-9,堪比水痘!且重症比例更高

7月31日,本土新增病例53例

7310—24时,31个省(自治区、直辖市)和新疆生产建设兵团报告新增确诊病例75例,其中境外输入病例22例(云南7例,上海5例,天津3例,内蒙古2例,广东2例,浙江1例,河南1例,四川1例),本土病例53例(江苏30例,河南12例,湖南4例,云南3例,福建1例,山东1例,湖北1例,宁夏1例);无新增死亡病例;新增疑似病例1例,为境外输入病例(在上海)。

河南省新冠疫苗接种超过1亿剂

截至7月31日,全省当日接种新冠疫苗993133人,全省累计接种100390482剂次。从今天开始,我们将同步推进青少年疫苗接种工作。计划在8月份开展15-17岁青少年第一剂接种,9月份开展12-14岁青少年第一剂接种,10月底前完成全程接种。

“德尔塔”下新冠疫情防控形势加强,我国正加快研究“加强针”

中国工程院院士李兰娟指出,要加快研究针对德尔塔变异株的“加强针”疫苗,以提高保护率。李兰娟透露:我所在的传染病诊治国家重点实验室已建立德尔塔变异株的灭活疫苗种子株,正与中国最大的新冠疫苗研发生产企业合作,全力以赴地推进德尔塔变异株疫苗的研发。

德尔塔”变异毒株是本次疫情反弹的元凶,在全球迅速蔓延且感染比例持续提升。根据世界卫生组织及GISAID数据,目前“德尔塔”变异毒株已经传播至全球132个国家(含地区),在近四周总递交检验样本中占比近90%。

日本连续三天日增新冠过万,民众扎堆奥运景点“打卡”,增加防疫难度

东京奥运会正如火如荼地进行,日本疫情近日也陡然恶化。据日本放送协会(NHK)报道,截至7月31日,日本已经连续第三天日增确诊病例数过万,7月31日当天新增确诊病例12341例,东京单日新增4058例,均创疫情暴发以来新高。

就在疫情反扑如此迅猛之际,之前抵制东京奥运会的日本人却纷纷走出家门,前往奥运会主场馆等一众奥运景点拍照“打卡”,为疫情防控带来新的困难。

由于疫情恶化,日本政府7月30日宣布,首都圈三县神奈川县、埼玉县、千叶县和大阪府8月2日至8月31日实施紧急状态。另外,正在东京都和冲绳县实施的紧急状态同样延长至8月31日。

福奇:德尔塔变异病毒致新冠病例激增 美国情况会变得更糟

当地时间1日,拜登政府首席医疗顾问安东尼·福奇接受美媒采访时表示,随着德尔塔变异病毒引发的新冠病例激增,美国情况可能变得更糟。

据美国有线电视新闻网报道,记者询问,美国是否会恢复封锁措施,以及病例激增是否只是暂时情况。福奇回应,他不认为美国会封锁,但随着新冠病例的增加,美国可能会经历苦难。

美国疾控中心最新统计数据显示,截至7月30日的一周内,美国新冠病例相较于一周前增加了64.1%。此外,目前7天平均每天有6071名新冠患者入院,这一数据也比7月16日至7月22日当周的数据增加了44%。此外,美疾控中心主任瓦伦斯基表示,全美进入医院的新冠肺炎患者中有97%以上未接种新冠疫苗。

以色列病例激增

全球新冠疫苗接种概况

Country
Cumulative COVID-19 vaccinations doses
World 4.14 billion
Asia 2.64 billion
Upper middle income 2.21 billion
China 1.65 billion
High income 1.20 billion
Lower middle income 721.72 million
Europe 648.16 million
North America 497.77 million
European Union 468.01 million
India Jul 30, 2021 461.52 million
United States 345.64 million
South America 266.56 million
Brazil 142.49 million
Germany Jul 30, 2021 92.05 million
United Kingdom Jul 30, 2021 84.94 million
Japan Jul 29, 2021 84.01 million
Turkey 73.27 million
France Jul 29, 2021 72.67 million
England Jul 30, 2021 71.15 million
Africa 68.67 million
Italy 68.51 million
Indonesia 67.76 million
Mexico 66.71 million
Russia 61.90 million
Spain Jul 29, 2021 56.19 million
Canada 49.29 million
Poland Jul 30, 2021 34.33 million
Argentina 31.88 million
Pakistan 29.65 million
Saudi Arabia 26.87 million
Colombia Jul 29, 2021 26.52 million
Chile Jul 28, 2021 25.48 million
South Korea 25.46 million
Morocco 23.76 million
Malaysia 20.53 million
Netherlands Jul 25, 2021 19.75 million
Philippines Jul 29, 2021 19.36 million
United Arab Emirates 16.80 million
Thailand Jul 25, 2021 15.96 million
Oceania 15.11 million
Belgium Jul 29, 2021 14.30 million
Peru Jul 30, 2021 12.94 million
Bangladesh 12.85 million
Australia 12.21 million
Portugal 12.12 million
Cambodia Jul 29, 2021 11.80 million
Sri Lanka 11.77 million
Ecuador Jul 30, 2021 11.22 million
Israel 11.16 million
Low income 10.85 million
Sweden Jul 30, 2021 10.57 million
Greece 10.54 million
Czechia 10.34 million
Iran Jul 26, 2021 10.17 million
Dominican Republic Jul 30, 2021 10.12 million

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2032384, encodeId=aca82032384a3, content=<a href='/topic/show?id=dfa39e45485' target=_blank style='color:#2F92EE;'>#防疫措施#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97454, encryptionId=dfa39e45485, topicName=防疫措施)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Wed Dec 22 13:39:03 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2010914, encodeId=5d922010914f2, content=<a href='/topic/show?id=a69c381136d' target=_blank style='color:#2F92EE;'>#变异病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38113, encryptionId=a69c381136d, topicName=变异病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Sat Jan 01 17:39:03 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764278, encodeId=02fa1e64278d1, content=<a href='/topic/show?id=967b66e9727' target=_blank style='color:#2F92EE;'>#激增#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66797, encryptionId=967b66e9727, topicName=激增)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=faa237702659, createdName=ms1756883563247400, createdTime=Mon Feb 21 07:39:03 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342868, encodeId=8ddb13428681f, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Tue Aug 03 22:39:03 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402611, encodeId=60101402611d7, content=<a href='/topic/show?id=546f9e45197' target=_blank style='color:#2F92EE;'>#防疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97451, encryptionId=546f9e45197, topicName=防疫)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf7e2418349, createdName=zhangying8789, createdTime=Tue Aug 03 22:39:03 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004565, encodeId=44da1004565f1, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd595227207, createdName=14791f6dm29(暂无昵称), createdTime=Mon Aug 02 09:33:46 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004556, encodeId=b0f0100455674, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8212476654, createdName=1244c0ebm28暂无昵称, createdTime=Mon Aug 02 09:15:49 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004541, encodeId=ab6f100454127, content=希望疫情控制快点起效, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65995533818, createdName=顿大侠, createdTime=Mon Aug 02 08:39:54 CST 2021, time=2021-08-02, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2032384, encodeId=aca82032384a3, content=<a href='/topic/show?id=dfa39e45485' target=_blank style='color:#2F92EE;'>#防疫措施#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97454, encryptionId=dfa39e45485, topicName=防疫措施)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Wed Dec 22 13:39:03 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2010914, encodeId=5d922010914f2, content=<a href='/topic/show?id=a69c381136d' target=_blank style='color:#2F92EE;'>#变异病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38113, encryptionId=a69c381136d, topicName=变异病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Sat Jan 01 17:39:03 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764278, encodeId=02fa1e64278d1, content=<a href='/topic/show?id=967b66e9727' target=_blank style='color:#2F92EE;'>#激增#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66797, encryptionId=967b66e9727, topicName=激增)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=faa237702659, createdName=ms1756883563247400, createdTime=Mon Feb 21 07:39:03 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342868, encodeId=8ddb13428681f, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Tue Aug 03 22:39:03 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402611, encodeId=60101402611d7, content=<a href='/topic/show?id=546f9e45197' target=_blank style='color:#2F92EE;'>#防疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97451, encryptionId=546f9e45197, topicName=防疫)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf7e2418349, createdName=zhangying8789, createdTime=Tue Aug 03 22:39:03 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004565, encodeId=44da1004565f1, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd595227207, createdName=14791f6dm29(暂无昵称), createdTime=Mon Aug 02 09:33:46 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004556, encodeId=b0f0100455674, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8212476654, createdName=1244c0ebm28暂无昵称, createdTime=Mon Aug 02 09:15:49 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004541, encodeId=ab6f100454127, content=希望疫情控制快点起效, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65995533818, createdName=顿大侠, createdTime=Mon Aug 02 08:39:54 CST 2021, time=2021-08-02, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2032384, encodeId=aca82032384a3, content=<a href='/topic/show?id=dfa39e45485' target=_blank style='color:#2F92EE;'>#防疫措施#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97454, encryptionId=dfa39e45485, topicName=防疫措施)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Wed Dec 22 13:39:03 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2010914, encodeId=5d922010914f2, content=<a href='/topic/show?id=a69c381136d' target=_blank style='color:#2F92EE;'>#变异病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38113, encryptionId=a69c381136d, topicName=变异病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Sat Jan 01 17:39:03 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764278, encodeId=02fa1e64278d1, content=<a href='/topic/show?id=967b66e9727' target=_blank style='color:#2F92EE;'>#激增#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66797, encryptionId=967b66e9727, topicName=激增)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=faa237702659, createdName=ms1756883563247400, createdTime=Mon Feb 21 07:39:03 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342868, encodeId=8ddb13428681f, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Tue Aug 03 22:39:03 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402611, encodeId=60101402611d7, content=<a href='/topic/show?id=546f9e45197' target=_blank style='color:#2F92EE;'>#防疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97451, encryptionId=546f9e45197, topicName=防疫)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf7e2418349, createdName=zhangying8789, createdTime=Tue Aug 03 22:39:03 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004565, encodeId=44da1004565f1, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd595227207, createdName=14791f6dm29(暂无昵称), createdTime=Mon Aug 02 09:33:46 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004556, encodeId=b0f0100455674, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8212476654, createdName=1244c0ebm28暂无昵称, createdTime=Mon Aug 02 09:15:49 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004541, encodeId=ab6f100454127, content=希望疫情控制快点起效, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65995533818, createdName=顿大侠, createdTime=Mon Aug 02 08:39:54 CST 2021, time=2021-08-02, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2032384, encodeId=aca82032384a3, content=<a href='/topic/show?id=dfa39e45485' target=_blank style='color:#2F92EE;'>#防疫措施#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97454, encryptionId=dfa39e45485, topicName=防疫措施)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Wed Dec 22 13:39:03 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2010914, encodeId=5d922010914f2, content=<a href='/topic/show?id=a69c381136d' target=_blank style='color:#2F92EE;'>#变异病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38113, encryptionId=a69c381136d, topicName=变异病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Sat Jan 01 17:39:03 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764278, encodeId=02fa1e64278d1, content=<a href='/topic/show?id=967b66e9727' target=_blank style='color:#2F92EE;'>#激增#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66797, encryptionId=967b66e9727, topicName=激增)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=faa237702659, createdName=ms1756883563247400, createdTime=Mon Feb 21 07:39:03 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342868, encodeId=8ddb13428681f, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Tue Aug 03 22:39:03 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402611, encodeId=60101402611d7, content=<a href='/topic/show?id=546f9e45197' target=_blank style='color:#2F92EE;'>#防疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97451, encryptionId=546f9e45197, topicName=防疫)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf7e2418349, createdName=zhangying8789, createdTime=Tue Aug 03 22:39:03 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004565, encodeId=44da1004565f1, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd595227207, createdName=14791f6dm29(暂无昵称), createdTime=Mon Aug 02 09:33:46 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004556, encodeId=b0f0100455674, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8212476654, createdName=1244c0ebm28暂无昵称, createdTime=Mon Aug 02 09:15:49 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004541, encodeId=ab6f100454127, content=希望疫情控制快点起效, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65995533818, createdName=顿大侠, createdTime=Mon Aug 02 08:39:54 CST 2021, time=2021-08-02, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2032384, encodeId=aca82032384a3, content=<a href='/topic/show?id=dfa39e45485' target=_blank style='color:#2F92EE;'>#防疫措施#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97454, encryptionId=dfa39e45485, topicName=防疫措施)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Wed Dec 22 13:39:03 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2010914, encodeId=5d922010914f2, content=<a href='/topic/show?id=a69c381136d' target=_blank style='color:#2F92EE;'>#变异病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38113, encryptionId=a69c381136d, topicName=变异病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Sat Jan 01 17:39:03 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764278, encodeId=02fa1e64278d1, content=<a href='/topic/show?id=967b66e9727' target=_blank style='color:#2F92EE;'>#激增#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66797, encryptionId=967b66e9727, topicName=激增)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=faa237702659, createdName=ms1756883563247400, createdTime=Mon Feb 21 07:39:03 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342868, encodeId=8ddb13428681f, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Tue Aug 03 22:39:03 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402611, encodeId=60101402611d7, content=<a href='/topic/show?id=546f9e45197' target=_blank style='color:#2F92EE;'>#防疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97451, encryptionId=546f9e45197, topicName=防疫)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf7e2418349, createdName=zhangying8789, createdTime=Tue Aug 03 22:39:03 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004565, encodeId=44da1004565f1, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd595227207, createdName=14791f6dm29(暂无昵称), createdTime=Mon Aug 02 09:33:46 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004556, encodeId=b0f0100455674, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8212476654, createdName=1244c0ebm28暂无昵称, createdTime=Mon Aug 02 09:15:49 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004541, encodeId=ab6f100454127, content=希望疫情控制快点起效, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65995533818, createdName=顿大侠, createdTime=Mon Aug 02 08:39:54 CST 2021, time=2021-08-02, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2032384, encodeId=aca82032384a3, content=<a href='/topic/show?id=dfa39e45485' target=_blank style='color:#2F92EE;'>#防疫措施#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97454, encryptionId=dfa39e45485, topicName=防疫措施)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Wed Dec 22 13:39:03 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2010914, encodeId=5d922010914f2, content=<a href='/topic/show?id=a69c381136d' target=_blank style='color:#2F92EE;'>#变异病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38113, encryptionId=a69c381136d, topicName=变异病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Sat Jan 01 17:39:03 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764278, encodeId=02fa1e64278d1, content=<a href='/topic/show?id=967b66e9727' target=_blank style='color:#2F92EE;'>#激增#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66797, encryptionId=967b66e9727, topicName=激增)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=faa237702659, createdName=ms1756883563247400, createdTime=Mon Feb 21 07:39:03 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342868, encodeId=8ddb13428681f, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Tue Aug 03 22:39:03 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402611, encodeId=60101402611d7, content=<a href='/topic/show?id=546f9e45197' target=_blank style='color:#2F92EE;'>#防疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97451, encryptionId=546f9e45197, topicName=防疫)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf7e2418349, createdName=zhangying8789, createdTime=Tue Aug 03 22:39:03 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004565, encodeId=44da1004565f1, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd595227207, createdName=14791f6dm29(暂无昵称), createdTime=Mon Aug 02 09:33:46 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004556, encodeId=b0f0100455674, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8212476654, createdName=1244c0ebm28暂无昵称, createdTime=Mon Aug 02 09:15:49 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004541, encodeId=ab6f100454127, content=希望疫情控制快点起效, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65995533818, createdName=顿大侠, createdTime=Mon Aug 02 08:39:54 CST 2021, time=2021-08-02, status=1, ipAttribution=)]
    2021-08-02 14791f6dm29(暂无昵称)

    学习

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2032384, encodeId=aca82032384a3, content=<a href='/topic/show?id=dfa39e45485' target=_blank style='color:#2F92EE;'>#防疫措施#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97454, encryptionId=dfa39e45485, topicName=防疫措施)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Wed Dec 22 13:39:03 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2010914, encodeId=5d922010914f2, content=<a href='/topic/show?id=a69c381136d' target=_blank style='color:#2F92EE;'>#变异病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38113, encryptionId=a69c381136d, topicName=变异病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Sat Jan 01 17:39:03 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764278, encodeId=02fa1e64278d1, content=<a href='/topic/show?id=967b66e9727' target=_blank style='color:#2F92EE;'>#激增#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66797, encryptionId=967b66e9727, topicName=激增)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=faa237702659, createdName=ms1756883563247400, createdTime=Mon Feb 21 07:39:03 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342868, encodeId=8ddb13428681f, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Tue Aug 03 22:39:03 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402611, encodeId=60101402611d7, content=<a href='/topic/show?id=546f9e45197' target=_blank style='color:#2F92EE;'>#防疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97451, encryptionId=546f9e45197, topicName=防疫)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf7e2418349, createdName=zhangying8789, createdTime=Tue Aug 03 22:39:03 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004565, encodeId=44da1004565f1, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd595227207, createdName=14791f6dm29(暂无昵称), createdTime=Mon Aug 02 09:33:46 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004556, encodeId=b0f0100455674, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8212476654, createdName=1244c0ebm28暂无昵称, createdTime=Mon Aug 02 09:15:49 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004541, encodeId=ab6f100454127, content=希望疫情控制快点起效, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65995533818, createdName=顿大侠, createdTime=Mon Aug 02 08:39:54 CST 2021, time=2021-08-02, status=1, ipAttribution=)]
    2021-08-02 1244c0ebm28暂无昵称

    学习学习

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2032384, encodeId=aca82032384a3, content=<a href='/topic/show?id=dfa39e45485' target=_blank style='color:#2F92EE;'>#防疫措施#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97454, encryptionId=dfa39e45485, topicName=防疫措施)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Wed Dec 22 13:39:03 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2010914, encodeId=5d922010914f2, content=<a href='/topic/show?id=a69c381136d' target=_blank style='color:#2F92EE;'>#变异病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38113, encryptionId=a69c381136d, topicName=变异病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Sat Jan 01 17:39:03 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764278, encodeId=02fa1e64278d1, content=<a href='/topic/show?id=967b66e9727' target=_blank style='color:#2F92EE;'>#激增#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66797, encryptionId=967b66e9727, topicName=激增)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=faa237702659, createdName=ms1756883563247400, createdTime=Mon Feb 21 07:39:03 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342868, encodeId=8ddb13428681f, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Tue Aug 03 22:39:03 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402611, encodeId=60101402611d7, content=<a href='/topic/show?id=546f9e45197' target=_blank style='color:#2F92EE;'>#防疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97451, encryptionId=546f9e45197, topicName=防疫)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf7e2418349, createdName=zhangying8789, createdTime=Tue Aug 03 22:39:03 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004565, encodeId=44da1004565f1, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd595227207, createdName=14791f6dm29(暂无昵称), createdTime=Mon Aug 02 09:33:46 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004556, encodeId=b0f0100455674, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8212476654, createdName=1244c0ebm28暂无昵称, createdTime=Mon Aug 02 09:15:49 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004541, encodeId=ab6f100454127, content=希望疫情控制快点起效, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65995533818, createdName=顿大侠, createdTime=Mon Aug 02 08:39:54 CST 2021, time=2021-08-02, status=1, ipAttribution=)]
    2021-08-02 顿大侠

    希望疫情控制快点起效

    0

相关资讯

美国CDC:新冠疫苗对新冠病毒突变株还有效吗?

美国CDC:新冠疫苗对新冠病毒突变株还有效吗?

2021年8月1日简报:德尔塔(Delta)毒株R0高达8-9,堪比水痘!且重症比例更高;7月全国新增本土病例328例,波及14省份

截至北京时间2021年8月1日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过19850万例,新增528,740例,达到198,501,220

Nat Med:CoronaVac灭活疫苗在自身免疫性风湿病患者中的免疫原性和安全性:4期临床试验 

目前,CoronaVac在免疫力低下的个体中的免疫原性还没有得到很好的证实。为此,研究人员启动了一项前瞻性的4期对照试验(编号:NCT04754698,CoronavRheum)。

JAMA Neuology:公众需要了解真相,神经系统功能性失调可能与疫苗接种无关

有效的沟通将有助于教育公众,减少恐惧,以便患者能够自己做出接受疫苗的知情决定,以降低新冠肺炎的风险。

2021年7月30日简报:全球疫苗接种超40亿剂次,中国超16亿剂次;南京疫情已蔓延至15省份26市,和新冠病毒共存,成为重要选项之一

截至北京时间2021年7月30日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过19727万例,新增628,392例,达到197,277,76

2021年7月31日简报:美国日增确诊病例再超10万例,死亡在500人以内;北京将启动12至14岁人群接种新冠疫苗;以色列为60岁以上人群接种第三剂新冠疫苗

截至北京时间2021年7月31日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过19795万例,新增636,167例,达到197,958,90